TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Sun Nov 23

NL

Article

gbudwell published an article 12:08 AM

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

Fri Nov 21

NL

Article

gbudwell published an article 1:28 AM

George Soros Just Bought These 3 Stocks: Should You?

Controversial billionaire George Soros purchased large stakes in AbbVie, Actavis plc, and Valeant Pharmaceuticals in the third-quarter. Should you follow in his footsteps?

Sat Nov 15

NL

Article

gbudwell published an article 1:49 AM

GlaxoSmithKline vs. Sanofi: Which Is The Better Dividend Stock?

Shares of healthcare giants GlaxoSmithKline and Sanofi have fallen hard this year, resulting in unusually high dividend yields for these two companies. Here is a look at which company offers the better opportunity for income investors moving forward. [more]

Wed Nov 12

NL

Article

gbudwell published an article 9:26 PM

AbbVie Inc. vs. Pfizer Inc.: Which Is the Better Dividend Stock?

AbbVie and Pfizer are top healthcare stocks offering sector-beating dividend yields. Which company is the better long-term buy for income investors?

NL

Article

gbudwell published an article 12:45 AM

Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015

Johnson & Johnson has had a great year largely because of its hepatitis C drug Olysio. This top dividend stock, though, might reverse course in 2015. Here's why.

Tue Nov 11

NL

Article

gbudwell published an article 6:22 AM

5 Things Actavis plc's Management Wants You to Know

Specialty and generic drugmaker Actavis plc reported another monster quarter last week. Here are five things management wants investors to know going forward.

Sun Nov 9

NL

Article

gbudwell published an article 10:47 PM

Bill Ackman vs. Allergan, Inc.: Who Will Win the War of Words?

Valeant Pharmaceuticals' takeover bid for Allergan has turned hostile in more ways than one.

Sat Nov 8

NL

Article

gbudwell published an article 11:41 PM

Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?

Arena Pharmaceuticals stock has fallen hard after a slower than expected launch of its fat-fighting pill Belviq. During its third-quarter conference call, though, management gave three reasons investors should be optimistic moving forward.

Wed Nov 5

NL

Article

gbudwell published an article 7:51 AM

Actavis plc's Strong Third-Quarter Earnings Reflect Its Acquisition Bonanza

Actavis posted third-quarter earnings this morning. Here's what you need to know.

Mon Nov 3

NL

Article

gbudwell published an article 12:30 AM

Is this MannKind Corporation's Worst Nightmare?

MannKind's long-awaited inhaled insulin product is nearing a commercial launch. The drug may be in for a bumpier ride than most expect, however. Here's why.

Sun Nov 2

NL

Article

gbudwell published an article 8:36 PM

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.

AbbVie isn't conceding defeat in the next-generation hepatitis C drug race. Here's why.

Thu Oct 30

NL

Article

gbudwell published an article 8:42 AM

Key Takeaways From Teva Pharmaceutical Industries Ltd.'s Third-Quarter Earnings

Specialty and generic drugmaker Teva reported third-quarter earnings last week. Here's what you need to know.

NL

Article

gbudwell published an article 4:44 AM

5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know

Bristol-Myers Squibb reported third-quarter earnings last week. Here are five things management wants investors to know.

Wed Oct 29

NL

Article

gbudwell published an article 8:53 PM

5 Things GlaxoSmithKline plc Stock's Management Wants You to Know

GlaxoSmithKline held its third-quarter conference call last week. Here's what the company's management wants you to know.

Mon Oct 27

NL

Article

gbudwell published an article 10:17 AM

Why Sarepta Therapeutics Inc Stock Is Crashing Today

Shares of clinical-stage biotech Sarepta Therapeutics fell by nearly 40% this morning. Here's why.

Fri Oct 24

NL

Article

gbudwell published an article 8:36 AM

Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street

Bristol-Myers Squibb reported third-quarter earnings this morning. Here's what you need to know.

Wed Oct 22

NL

Article

gbudwell published an article 8:36 AM

Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings

British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.

NL

Article

gbudwell published an article 3:51 AM

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

Mon Oct 20

NL

Article

gbudwell published an article 9:44 AM

Will Marijuana-Based Pharmaceuticals Make Drugs More Affordable?

Marijuana-based pharmaceuticals are becoming a reality. Will these "natural" products come with the added benefit of lower price tags compared to their man-made counterparts?

NL

Article

gbudwell published an article 8:13 AM

Is Johnson & Johnson's Worst Nightmare Becoming Reality?

Johnson & Johnson has become a growth story on the back of strong pharmaceutical sales over the past two quarters. This trend looks like it is about to change with the approval of a rival's game-changing drug.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75069
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick RXII (+9.56)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts